The clonogenic precursor cell in multiple myeloma.
Multiple myeloma is characterized by the monoclonal expansion of plasma cells in the bone marrow. Although the predominant cell type is the plasma cell, the initial oncogenic transformation is considered to take place in a more immature B cell. There is still much controversy about this precursor cell type. Phenotypic analysis of bone marrow and peripheral blood revealed that in multiple myeloma a great diversity exists in the phenotype of the cells considered to be involved. Because of the lack of a myeloma specific genetic lesion it is very difficult to trace back the cell in which the transforming event, leading to multiple myeloma, took place. The only real clonal marker is the idiotype of the immunoglobulin molecule expressed by the myeloma cells. With recombinant DNA technology it is now possible to produce clonal markers for each individual myeloma patient which recognize only the immunoglobulin genes expressed by the myeloma cell and its precursors. The sequences of these myeloma immunoglobulin genes do reveal a lot of information about the stage in the B-cell differentiation pathway in which the oncogenic event might have taken place. The presence of somatic mutations in a non-random fashion without intraclonal variation leads to the conclusion that the precursor myeloma cell could not possibly be a pre-B cell or stem cell but has to be a mature B cell that has been in contact with antigen and has past through the phase of somatic mutation, like a memory B cell or plasmablast.(ABSTRACT TRUNCATED AT 250 WORDS)
Dept. of Hematology-Immunology, Medical School, Vrije Universiteit Brussel (VUB), Belgium.
M H
MH
Bakkus
I
I
Van Riet
C
C
De Greef
B
B
Van Camp
K
K
Thielemans
D001402:B-Lymphocytes / Q000166:cytology; D002454:Cell Differentiation / Q000235:genetics; D006801:Humans; D007136:Immunoglobulins / Q000235:genetics; D009101:Multiple Myeloma / Q000235:genetics / Q000473:pathology*; D010641:Phenotype; D014410:Tumor Stem Cell Assay
D007136:Immunoglobulins